Double blind, placebo-controlled, efficacy and safety study of clobazam in patients with Lennox-Gastaut syndrome.
Phase of Trial: Phase III
Latest Information Update: 27 Apr 2018
At a glance
- Drugs Clobazam (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Registrational; Therapeutic Use
- Acronyms CONTAIN
- Sponsors Lundbeck Inc
- 27 Apr 2018 Results of a post-hoc analysis presented at the 70th Annual Meeting of the American Academy of Neurology.
- 27 Apr 2018 Population PK modeling results Study 301, OV-1017 and OV-1012, presented at the 70th Annual Meeting of the American Academy of Neurology
- 05 Dec 2017 Results of post hoc analysis presented at the 71st Annual Meeting of the American Epilepsy Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History